TY - CHAP M1 - Book, Section TI - Preinvasive Lesions of the Lower Anogenital Tract A1 - Hoffman, Barbara L. A1 - Schorge, John O. A1 - Halvorson, Lisa M. A1 - Hamid, Cherine A. A1 - Corton, Marlene M. A1 - Schaffer, Joseph I. PY - 2020 T2 - Williams Gynecology, 4e AB - Office gynecology includes the diagnosis and management of preinvasive lower anogenital tract (LAGT) disease, most often involving the uterine cervix, but also the vulvar, vaginal, perianal, and anal epithelia. An understanding of human papillomavirus (HPV) as the causative agent of most LAGT neoplasia has greatly advanced screening, diagnosis, management, and prevention efforts. Importantly, in current clinical practice, evidence-based knowledge is ever evolving and translates into rapidly changing patient-care recommendations. Although most study findings and clinical guidelines to date refer to women, these are applicable to the care of some transgender men (Hembree, 2017). SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1171532888 ER -